drugset / Trial / NCT02648958
Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations
RandomizedParallel-groupDouble-blindPrevention
Summary
Ischemia reperfusion injury causes the release of free oxygen radicals. The selective alpha2-receptor agonist, dexmedetomidine, has an inhibitory effect on inflammatory responses during ischemic injury. The aim of this study is to evaluate the effect of dexmedetomidine on inflammatory responses during ischemia-reperfusion injury in skeletal muscle.
Timeline
- Start
- 2016-01
- Primary completion
- 2017-07-31
- Completion
- 2017-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.4 mg/kg | — |